HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection of the STAT5B-RARA fusion transcript in acute promyelocytic leukemia with the normal chromosome 17 on G-banding.

Abstract
Acute promyelocytic leukemia (APL) is characterized by chromosomal rearrangements of 17q21, leading to fusion of the gene-encoding retinoic acid receptor alpha (RARA) with a number of alternative partner genes. Signal transducer and activator of transcription 5 beta (STAT5B) is one of the alternative partners. We report a rare case of APL with STAT5B-RARA fusion transcript and the normal chromosome 17 on G-banding. Administration of all trans-retinoic acid improved disseminated intravascular coagulation without decrease of the leukemia cells in his peripheral blood and bone marrow. The molecular mechanism of fusion between STAT5B and RARA by chromosomal rearrangement is discussed based on the data from genome database. Clinical characteristics of APL with STAT5B-RARA are also discussed.
AuthorsManabu Kusakabe, Kazumi Suzukawa, Toru Nanmoku, Naoshi Obara, Yasushi Okoshi, Harumi Y Mukai, Yuichi Hasegawa, Hiroshi Kojima, Yasushi Kawakami, Haruhiko Ninomiya, Toshiro Nagasawa
JournalEuropean journal of haematology (Eur J Haematol) Vol. 80 Issue 5 Pg. 444-7 (May 2008) ISSN: 1600-0609 [Electronic] England
PMID18221386 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Oncogene Proteins, Fusion
  • STAT5 Transcription Factor
  • STAT5-RARalpha protein, human
Topics
  • Adult
  • Aged
  • Amino Acid Sequence
  • Base Sequence
  • Chromosomes, Human, Pair 17 (genetics)
  • Humans
  • Karyotyping
  • Leukemia, Promyelocytic, Acute (genetics)
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Oncogene Proteins, Fusion (analysis, chemistry, genetics)
  • STAT5 Transcription Factor (analysis, chemistry, genetics)
  • Transcription, Genetic (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: